Pantoprazolo Zentiva (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazolo Zentiva, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pantoprazolo Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazolo Zentiva is a proton pump inhibitor that acts on the gastric acid secretion pathway. - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of esophageal erosion. - Erosive gastritis and duodenal ulcers: accelerates ulcer healing by maintaining a less acidic gastric environment. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare endocrine disorder.

Pantoprazolo Zentiva is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: infrequent bowel changes.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile‑associated colitis: may present with profuse watery diarrhea. - Low magnesium levels (hypomagnesemia): can cause muscle cramps or cardiac arrhythmia. - Bone fractures: long‑term use may be linked to decreased bone mineral density. - Liver enzyme elevation: indicates possible hepatic involvement. - Acute interstitial nephritis: rare kidney inflammation.

When prescribing Pantoprazolo Zentiva, consider the following safety measures: - Assess renal function: dose adjustment may be required in severe impairment. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Monitor long‑term use: evaluate need for continued therapy after several months. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Elderly patients: start with the lowest effective dose and monitor for adverse effects. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazolo Zentiva can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Ketoconazole and itraconazole: reduced antifungal absorption due to increased gastric pH. - Atazanavir and nelfinavir: markedly decreased antiviral efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring more frequent coagulation monitoring. - Methotrexate: elevated serum levels may occur, especially at high doses. - Digoxin: slight increase in serum concentration, warranting periodic level checks.